The Indian Pharmaceutical Alliance (IPA) recently concluded the 8th edition of the Global Pharmaceutical Quality Summit in Mumbai. Minister for Chemicals & Fertilizers and Health & Family Welfare, Government of India, Dr Mansukh Mandaviya delivered his address during the closing ceremony.

The Minister said that no country complained about the quality of the medicines as the Indian pharma industry never compromises with the quality of the medicines. "We know that like all the other sectors there are few people who try to compromise with the quality of the products. But they should always remember that the government has zero tolerance policy against these element", Dr Mandaviya said. 

He further informed that Government is taking stringent actions against the companies involved in such type of malpractices. He urged the pharma industry to establish a self regulatory body to monitor the quality of  pharma products. He also added that the country is marching ahead in the field of research and innovation as the government has opened its research facilities to all including the private sector.

The theme for the Summit was, ‘Patient Centricity: New Paradigm of Manufacturing and Quality’.

The two-day Summit brought together industry leaders, global regulators, quality experts, and stakeholders to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India.

The highlight of the day was the panel discussion comprising leading CEOs of the pharma industry from Cipla, Dr Reddy’s, Lupin, Sun Pharma and Zydus providing their thoughts on the future of the Indian pharmaceutical industry.

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, said, “Quality is the fundamental tenet of the pharmaceutical sector. Continuous investments in quality –systems, technology, and talent – is fundamental as the overall healthcare landscape is evolving at an unprecedented pace."